Immune Inflammation Indicators Predict Outcome in Anal Cancer Patients Undergoing Concurrent Chemoradiation

Systemic inflammatory response has been shown to reflect the promotion of angiogenesis, DNA damage and tumor invasion through up-regulation of cytokines. Several inflammation and immune-based prognostic scores, such as lymphocyte count, neutrophil-lymphocyte ratio (NLR) and systemic immune-inflammation index (SII) have been developed to predict survival and recurrence in different oncological settings. In the present study, we investigated the...